Ginsenosides Protect the High Glucose-induced Stimulation of IGFs in Mesangial Cells |
Bae, Chun-Sik
(College of Veterinary Medicine, Biotechnology Research Institute,Chonnam National University)
Lim, Do-Seon (Department of Dental Hygiene, Eulji University) Yoon, Byeong-Cheol (College of Veterinary Medicine, Biotechnology Research Institute,Chonnam National University ) Jeong, Moon-Jin (Department of Oral Histology, College of Dentistry, Chosun University) Yoon, Kyung-Chul (Department of Ophthalmology, Chonnam National University, Medical School and Hospital) Park, Soo-Hyun (Functional Food Center, Chonnam National University) |
1 | Elliot, S. J., L. J. Striker, M. Hattori, C. W. Yang, C. J. He, E. P. Peten and G. E. Striker. 1993. Mesangial cells from diabetic NOD mice constitutively secrete increased amounts of insulin-like growth factor-I. Endocrinology 133, 1783-1788. DOI ScienceOn |
2 | Lenz, O, S. J. Elliot and W. G. Stetler-Stevenson, 2000. Matrix metalloproteinases in renal development and disease. J. Am. Soc. Nephrol. 11, 574-581. |
3 | Yamagishi, S., K. Fukami, S. Ueda and S. Okuda. 2007. Molecular mechanisms of diabetic nephropathy and its therapeutic intervention. Curr. Drug Targets. 8, 952-959. DOI ScienceOn |
4 | Ohkawa, H., N. Ohishi and K. Vagi. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351-358. DOI ScienceOn |
5 | Okada, T., J. Wada, K. Hida, J. Eguchi, I. Hashimoto, M. Baba, A. Yasuhara, K. Shikata and H. Makino. 2006. Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms. Diabetes 55, 1666-1677. DOI ScienceOn |
6 | Park, C. W., J. H. Kim, J. H. Lee, Y. S. Kim, H. J. Ahn, Y. S. Shin, S. Y. Kim, E. J. Choi, Y. S. Chang and B. K. Bang. 2000. High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-kappa B-dependent. Diabetologia 43, 1544-1553. DOI ScienceOn |
7 | Segev, Y., R. Eshet, O. Yakir, N. Haim, M. Phillip and D. Landau. 2007. Systemic and renal growth hormone-IGF 1 axis involvement in a mouse model of type 2 diabetes. Diabetologia. 50, 1327-1334. DOI ScienceOn |
8 | Sheetz, M. J. and G. L. King. 2002. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. J.A.M.A. 288, 2579-2588. DOI ScienceOn |
9 | Thrailkill, K. M. 2000. Insulin-like growth factor-I in diabetes mellitus: its physiology, metabolic effects, and potential clinical utility. Diabetes Technol. Ther. 2, 69-80. DOI ScienceOn |
10 | Waki, I., H. Kyo, M. Yasuda and M. Kimura. 1982. Effects of a hypoglycemic component of ginseng radix on insulin biosynthesis in normal and diabetic animals. J. Pharmacobiodyn. 5, 547-554. DOI |
11 | Wardle, E. N. 1996. How does hyperglycaemia predispose to diabetic nephropathy? Q.J.M. 89, 943-951. DOI ScienceOn |
12 | Catherwood, M. A, L. A Powell, P. Anderson, D. McMaster, P. C. Sharpe and E. R. Trimble. 2002. Glucose-induced oxidative stress in mesangial cells. Kidney Int. 61, 599-608. DOI ScienceOn |
13 | Anderson, M. E. 1989. Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol. 113, 548-554. |
14 | Bowsher, R. R., W. H. Lee, J. M. Apathy, P. J. O'Brien, A. L. Ferguson and D. P. Henry. 1991. Measurement of insulin-like growth factor-II in physiological fluids and tissues. I. An improved extraction procedure and radioimmunoassay for human and rat fluids. Endocrinology 128, 805-814. DOI ScienceOn |
15 | Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254. DOI ScienceOn |
16 | Cho, W. C. W. S. Chung, S. K. Lee, A. W. Leung, C. H. Cheng and K. K. Yue. 2006. Ginsenoside Re of Panax ginseng possesses significant antioxidant and anti-hyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur. J. Pharmacol. 21, 173-179. |
17 | Cummings, E. A, E. B. Sochett, M. G. Dekker, M. L. Lawson and D. Daneman. 1998. Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes. Diabetes 47, 1341-1346. DOI ScienceOn |
18 | Daughaday, W. H. and P. Rotwein. 1989. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocrine Rev. 10, 68-91. DOI ScienceOn |
19 | Kim, H. Y., K. S. Kang, N. Yamabe, R. Nagai and T. Yokozawa. 2007. Protective effect of heat-processed American ginseng against diabetic renal damage in rats. J. Agric. Food Chem., 55, 8491-8497. DOI ScienceOn |
20 | Xie, J. T., S. R. Mehendale, A. Wang, A. H. Han, J. A. Wu, J. Osinski and C. S. Yuan. 2004. American ginseng leaf: ginsenoside analysis and hypoglycemic activity. Pharmacol. Res. 49, 113-117. DOI ScienceOn |
21 | Lee, H. B., J. Y. Seo, M. R. Yu, S. T. Uh and H. Ha. 2007. Radical approach to diabetic nephropathy. Kidney Int. Suppl. 106, S67-S70. |
22 | Werner, H., Z. Shen-Orr, B. Stannard, B. Burguera, C. T. Jr. Roberts and D. LeRoith. 1990. Experimental diabetes increases insulinlike growth factor I and II receptor concentration and gene expression in kidney. Diabetes 39, 1490-1497. DOI ScienceOn |
23 | Li, N., B. Liu, D. E. Dluzen and Y. Jin. 2007. Protective effects of ginsenoside Rg2 against glutamate-induced neurotoxicity in PC12 cells. J. Ethnopharmacol. 111, 458-463. DOI ScienceOn |
24 | Liao, B., H. Newmark and R. Zhou. 2002. Neuroprotective effects of ginseng total saponin and ginsenosides Rb1 and Rg1 on spinal cord neurons in vitro. Exp. Neurol. 173, 224-234. DOI ScienceOn |
25 | Miyatake, N., K. Shikata, J. Wada, H. Sugimoto, S. Takahashi and H. Makino. 1999. Differential distribution of insulin-like growth factor-I and insulin-like growth factor binding proteins in experimental diabetic rat kidney. Nephron 81, 317-323. DOI ScienceOn |
26 | Francki, A., K. Motamed, T. D. McClure, M. Kaya, C. Murri, D. J. Blake, J. G. Carbon and E. H. Sage. 2003. SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling. J. Cell Biochem. 88, 802-811. DOI ScienceOn |
27 | Xing, M., L. Tao and P. A. Insel. 1997. Role of extracellular signal-regulated kinase and PKC alpha in cytosolic PLA2 activation by bradykinin in MDCK-D1 cells. Am. J. Physiol. 272, C1380-1387. DOI |
28 | Xu, Z. G, S. L. Li, L. Lanting, Y. S. Kim, N. Shanmugam, M. A. Reddy and R. Natarajan. 2006. Relationship between 12/15-lipoxygenase and COX-2 in mesangial cells: potential role in diabetic nephropathy. Kidney Int. 69, 512-519. DOI ScienceOn |
29 | Flyvbjerg, A., D. Landau, H. Domene, L. Hernandez, H. Gronbaek and D. LeRoith. 1995. The role of growth hormone, insulin-like growth factors (IGFs), and IGF-binding proteins in experimental diabetic kidney disease. Metabolism 44, 67-71. |
30 | Ha, H. and H. B. Lee. 2001. oxidative stress in diabetic nephropathy: basic and clinical information. Curr. Diab. Rep. 1, 282-287. DOI ScienceOn |
31 | Kamata, K., M. Hosokawa, T. Matsumoto and T. Kobayashi. 2006. Altered arachidonic acid-mediated responses in the perfused kidney of the streptozotocin-induced diabetic rat. J. Smooth Mus. Res. 42, 171-187. DOI ScienceOn |
32 | Kiefer, D. and T. Pantuso. 2003. Panax ginseng. Am. Fam. Physician 68, 1539-1542. |
33 | Kim, H. Y. and K. Kim. 2007. Protective effect of ginseng on cytokine-induced apoptosis in pancreatic beta-cells. J. Agric. Food Chem. 55, 2816-2823. DOI ScienceOn |
34 | Yip, T. T., C. N. Lau, Y. C. Kong, K. H. Yung, J. H. Kim and W. S. Woo. 1985. Ginsenoside compositions of Panax ginseng C.A. Meyer tissue culture and juice. Am. J. Chin. Med. 13, 89-92. DOI ScienceOn |
35 | Fan, Y. P. and R. H. Weiss. 2004. Exogenous attenuation of p21 (Waf1/Cip1) decreases mesangial cell hypertrophy as a result of hyperglycemia and IGF-1. J. Am. Soc. Nephrol. 15, 575-584. DOI ScienceOn |